Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol and xanthine oxidase–derived free radicals in skeletal muscle mitochondrial alterations in type 2 diabetes
2010-023433-35Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Allopurinol with Placebo (2 arms). Primary endpoint: Muscle oxidative stress. Started Feb 2011; status: completed.
02
Drugs
allopurinol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-023433-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023433-35.